Search

everythinglearnresearchcommunity

for

Search:↓

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Targeting specific T cells may help treat alopecia areata.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

The Chinese herbal supplement BeauTop can potentially boost hair growth and thickness by increasing a protein called Vascular Endothelial Growth Factor.

New mouse models of Pemphigus show severe symptoms and need better treatments.

Glucosylceramides are essential for healthy skin and proper wound healing.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Anti-Ro exposed children had more reported neuro-psychiatric issues, but differences from healthy controls were not significant.

Minoxidil-loaded hyaluronic acid microneedles can effectively increase hair growth and could be a promising treatment for hair loss.